Authors | Koji Sasaki, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Koichi Takahashi, Marina Konopleva, Gautam Borthakur, Guillermo Garcia-Manero, William Wierda, Naval Daver, Preetesh Jain, Toshihisa Satta, Sherry Pierce, May Beth Rios, Jorge E Cortes |
Journal | Haematologica
(Haematologica)
Vol. 101
Issue 8
Pg. e324-7
(08 2016)
ISSN: 1592-8721 [Electronic] Italy |
PMID | 27175025
(Publication Type: Comparative Study, Letter)
|
Chemical References |
- Protein Kinase Inhibitors
- Pyrimidines
- Imatinib Mesylate
- Protein-Tyrosine Kinases
- nilotinib
- Dasatinib
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Dasatinib
(therapeutic use)
- Humans
- Imatinib Mesylate
(pharmacology, therapeutic use)
- Leukemia, Myeloid, Chronic-Phase
(drug therapy, mortality)
- Middle Aged
- Propensity Score
- Protein Kinase Inhibitors
(pharmacology, therapeutic use)
- Protein-Tyrosine Kinases
(antagonists & inhibitors)
- Pyrimidines
(therapeutic use)
- Survival Analysis
- Treatment Outcome
- Young Adult
|